(Yicai) Oct. 30 -- Leaders from the nine cities along the Shanghai-Nanjing Industrial Innovation Belt in the Yangtze River ...
An increasing number of Chinese companies have established offices in the Dubai Multi Commodities Center (DMCC) — the largest free trade zone in the United Arab Emirates — which has become a regional ...
One-on-one and group investor meetings on November 5 Stifel 2025 Healthcare Conference: Presentation on November 13 at 2:40 pm EST (NASDAQ: AAPG; HKEX: 6855) (“ Ascentage Pharma ” or the “ Company ”) ...
P.M. News on MSN
Geographical Indications: The Untapped Goldmine in Nigeria’s Intellectual Property Landscape
By Somadina Eugene OkorieFor centuries, civilizations have consistently associated certain products with their places of origin — for instance, wines from Bordeaux, silks from Suzhou, olive oil from ...
Workers from State-builder China Railway No 4 Engineering Group (CREC4) started laying tracks for the whole line of ...
Sportschosun on MSN
Will it be possible on the vast continent...Super League also begins discussion on Choo Chun-je
Is it a feasible idea in the world's fourth-largest area 'Continental'.The Chinese Super League is drawing attention as it ...
Shangri-La Group (“the Group”) proudly announces the grand opening of Shangri-La Hongqiao Airport and Traders Hongqiao Airport, Shanghai ...
Club Calvi has three choices for its next book: "This is the Next Kingdom" by Jaquira Díaz, "Bad Bad Girl" by Gish Jen, and ...
Journalist Jo Ling Kent joined CBS News in July 2023 as the senior business and technology correspondent for CBS News. Kent has more than 15 years of experience covering the intersection of technology ...
Fethiye Municipality represents Turkey at an international seminar in China on digital transformation in tourism ...
The last three years have been the toughest for Xie Dandan and her family during more than a decade cultivating one of China's most esteemed culinary delicacies, the "hairy crab", named for its furry ...
The drug, JSKN003, showed promising early efficacy in colorectal cancer patients in China in a Phase I/II trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results